Predict
Predict S.p.A. is a publicly-traded Italian healthcare technology company that distributes GE HealthCare diagnostic imaging systems and develops proprietary Mistral (breath-based cancer screening), Optip (telemedicine), and Aphel (social robotics) platforms, serving Italian hospitals, public health authorities, and research institutions.
- Company typePublic
- Founded2008
- HeadquartersBari, Italy
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Predict does
Predict S.p.A. is an Italian healthcare technology company headquartered in Bari, founded in 2008 to distribute GE HealthCare diagnostic imaging systems. Since 2015 the company has layered proprietary digital health platforms onto its distribution core, producing a three-pillar innovation portfolio: Mistral, an AI-powered breath analysis sampler for non-invasive screening of oncological and respiratory pathologies through exhaled volatile organic compounds; Optip, an augmented-reality teleconsultation platform enabling real-time remote specialist guidance during ultrasound examinations; and Aphel, a collaborative humanoid robot integrating ChatGPT-based large language models for patient interaction, hospital reception, pediatric entertainment, and museum guidance applications. Underlying technology spans machine-learning pattern recognition for clinical and breath data, computer-vision-assisted diagnostic imaging, and multimodal AI combining speech, imaging, and structured data streams.
The company serves Italian public-sector healthcare institutions (hospitals, Aziende Sanitarie Locali, emergency 118 services), research centers (IRCCS, universities), and educational/museum facilities. Revenue is generated through a hybrid model combining hardware sales of GE HealthCare ultrasound, mammography, densitometry, and radiology equipment with recurring subscription and license fees from proprietary software platforms, supplemented by professional services for installation, training, and maintenance. Distribution channels include a direct enterprise sales force, active bidding on public procurement tenders (MEPA/CONSIP and regional ASL tenders), and the predictstore.it e-commerce storefront. Predict completed its IPO on Euronext Growth Milan in September 2024, transitioned from S.r.l. to S.p.A., and has expanded its presence with new offices in Milan (October 2025) and Rome (April 2026). The majority shareholder is Qo3 S.r.l. (76.94% of shares), controlled by founder-CEO Angelo Gigante, with the public free float at approximately 22.43%.
Predict firmographics
Firmographics- Name
- Predict
- Legal name
- PREDICT S.p.A.
- Website
- https://predictcare.it
- Company type
- Public
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Predict S.p.A. is a publicly-traded Italian healthcare technology company that distributes GE HealthCare diagnostic imaging systems and develops proprietary Mistral (breath-based cancer screening), Optip (telemedicine), and Aphel (social robotics) platforms, serving Italian hospitals, public health authorities, and research institutions.
- Ownership category
- akta.pro rank
Predict industry classification
Industry- Product category
- Healthcare Technology (Medical Imaging & Digital Health)
- NAICS
- Diagnostic Imaging Centers (621512), Software Publishers (5132), Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Services-Health Services (8000), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Medical Imaging AI (HDAAAEAH)
- akta.pro secondary industries
- Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic) (HLACALAD), Imaging & Diagnostic Interoperability (DICOM exchange, image sharing, VNA connectivity) (HLACABAM), Oncology Remote Symptom Monitoring & Care Navigation (HLALAFAD)
Keywords
Where Predict is headquartered
LocationHeadquarters
- HQ city
- Bari
- HQ country
- Italy
- HQ region
- Europe
Offices3 records
Markets served
Predict business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Diagnostic Imaging Equipment Sales: Distribution and sale of GE HealthCare ultrasound and radiological systems (ecographers, mammographs, densitometers) with installation, training, and technical support services
- Digital Healthcare Platforms: Subscription and license fees for proprietary platforms including Optip (telemedicine), Mistral (breath analysis), Aphel (robotics), with associated professional services
- Professional Services: Technical support, training, maintenance, and consulting services for medical equipment and digital health solutions
- Digital Healthcare Solutions: Digital healthcare division showing strong acceleration, including software platforms and integrated solutions for healthcare institutions
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | GE HealthCare diagnostic imaging equipment pricing varies by system type and configuration |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels8 records
Predict product offering
Product offeringCore offering
Predict S.p.A. develops and distributes healthcare technology combining proprietary AI-powered digital health platforms—Mistral (breath analysis for early cancer screening), Optip (augmented-reality telemedicine for remote ultrasound guidance), and Aphel (LLM-powered social robotics for healthcare and education)—with exclusive Italian distribution of GE HealthCare diagnostic imaging systems (ultrasound, radiology, mammography, densitometry). The company sells, installs, and supports this portfolio directly to hospitals, ASLs (local health authorities), research institutions, and educational facilities in Italy.
Product overview
Predict S.p.A. is an Italian healthcare technology company offering a multi-product portfolio combining medical device distribution with proprietary digital health innovations. The portfolio centers on three proprietary platforms—Aphel (social robotics), Mistral (breath analysis), and Optip (telemedicine)—complemented by distribution of GE HealthCare diagnostic imaging systems and supporting technologies (InBody BIA, SwiftMR, Steripro). Predict operates as a quoted company (Euronext Growth Milan) serving hospitals, clinics, research institutions, and educational facilities across Italy, with offices in Bari, Milan, and Rome.
Differentiator
Problem solved
Functional benefit
Brands
- Aphel: Collaborative robot platform for patient and healthcare staff support, including humanoid robots for museums, hospitals, and pediatric wards.
- Mistral
- Optip
Products and services
- Mistral (Mistral Sampler) Breath analysis device (sampler) for early, non-invasive screening of oncological and respiratory pathologies. The technology extracts the breathprint—unique volatile organic compounds in exhaled breath—reflecting the physio-pathological state of the human system. AI algorithms recognize patterns in exhaled data to identify alterations related to prostate, breast, lung, and colorectal cancers. Sold to hospitals, research institutions, and universities for clinical and research use.
- Optip Telemedicine and teleconsultation platform based on augmented and mixed reality. Enables real-time remote specialist support during ultrasound examinations using AR headsets, allowing remote clinicians to view live examination video and hospital ultrasound imaging simultaneously. Includes Optip Bodycam integrated platform for emergency service (118) worker safety. Used for intra- and extra-hospital teleconsultation, second opinions, and remote patient monitoring by hospitals, ASLs, and emergency services.
- Aphel
Quantifiable outcome
- 14.6% revenue growth reaching €7.6 million in 2025 with Digital Healthcare accelerating
- +2 more outcomes
Companies that use Predict
Customer profileNamed customers10 records
Segments3 records
Ideal customer profiles2 records
Predict technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability9 records
Feature5 records
Predict partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core, minor and major.
- Vhit RoboticscoreConnexa Robotics alliance formed with Vhit Robotics and Weatecho to advance Hospital 4.0 in Italy, combining robotics, digital health, and AI technologies.
- WeatechocoreNetwork contract signed to jointly develop Hospital 4.0 solutions combining Predict's digital health platforms with Weatecho's technologies for integrated smart hospital systems.
- InnovapugliaminorAwarded framework agreement for ICT application services, system management, and support as part of RTI (temporary joint venture).
- Shenzhen SpinQ TechnologyminorDistribution agreement for SpinQ quantum computers (Triangulum II) for educational purposes in Italian schools, strengthening Digital Healthcare business unit.
- Airs Medical EuropeminorDistribution agreement for MRI systems with AI capabilities to complement existing diagnostic imaging portfolio.
- UVC SolutionsminorDistribution agreement for hospital environment disinfection devices (Steripro) to expand product portfolio.
- Sapienza University of RomemajorD3-4HEALTH research grant worth €341,000 for early colorectal cancer diagnosis research using breath analysis technology and AI algorithms.
- GE HealthCarecoreLong-standing exclusive distribution partnership for GE HealthCare diagnostic imaging equipment in Italy including ultrasound, radiology, mammography, and densitometry systems. GE provides product training, technical updates, and marketing support while Predict handles sales, installation, and after-sales service in the Italian market.
Scale indicators9 records
Recent moves6 records
Expansion highlights6 records
Predict competitors and assessment
Company assessmentDirect peers
- Esaote: Italian-headquartered diagnostic imaging manufacturer (ultrasound, MRI) with similar product portfolio and Italian roots. Most directly comparable peer given overlapping customer base (hospitals, clinics) and imaging modality focus, though Esaote is a global product OEM rather than a distributor-plus-software model.
- Owlstone Medical: UK-based breath biopsy company developing non-invasive breath tests for cancer and respiratory disease detection. Direct competitor to Predict's Mistral platform in exhaled-breath diagnostics, sharing the same clinical value proposition and biomarker discovery approach.
Broad incumbents
- Philips Healthcare: Global medtech incumbent offering ultrasound, radiology, AI-enabled imaging, and teleconsultation solutions. Competes with Predict across its GE-distributed imaging business and Optip telemedicine platform, but at vastly larger scale and with broader product breadth.
- Intuitive Surgical: Global leader in surgical and clinical robotics with da Vinci platform. Sets the bar in healthcare robotics that Predict's Aphel humanoid robot must compete with for hospital budgets and clinical acceptance, though their focus is surgical rather than social/assistive.
- Hologic: US-based women's health and diagnostics company with mammography and breast health franchises. Comparable to Predict's mammography distribution line and Mistral's breast-cancer screening application, though Hologic is a global OEM rather than a distributor.
- Siemens Healthineers: Global imaging and diagnostics giant with ultrasound, mammography, and AI-Rad Companion AI platform. Direct competitor to Predict's GE-distributed portfolio and a benchmark for AI-enabled diagnostic imaging, but operates at global scale across multiple modalities.
- GE HealthCare: Global medical imaging leader whose products Predict distributes in Italy; also a strategic partner. Relevant peer because Predict's distribution business is exposed to GE's commercial decisions, and GE's own Edison AI platform competes with Predict's imaging-AI features.
- Mindray: Global medical device and imaging company offering ultrasound and patient monitoring systems with embedded AI. Competes with Predict's GE-distributed ultrasound franchise and increasingly with European digital health platforms.
Emerging players
- Tempus AI: AI-driven precision medicine company combining molecular data and clinical data for cancer diagnosis and treatment. Competes conceptually with Mistral in the AI-enabled early-cancer detection space, but uses genomic rather than breath-based biomarkers.
- Teladoc Health: Global telehealth platform serving hospitals, employers, and patients with virtual care solutions. Direct competitor to Predict's Optip telemedicine/teleconsultation platform in the broader virtual-care market, though Teladoc operates at much larger scale and broader clinical scope.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Predict social profiles
Digital presencePredict compliance and trust
Trust signalCompliance3 records
Predict financial estimates
Financial estimateRevenue estimate
Valuation estimate
Predict leadership team
Management profileNumber of profiles
Profiles4 records
Predict funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Predict M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Predict
What does Predict do?
Predict S.p.A. develops and distributes healthcare technology combining proprietary AI-powered digital health platforms—Mistral (breath analysis for early cancer screening), Optip (augmented-reality telemedicine for remote ultrasound guidance), and Aphel (LLM-powered social robotics for healthcare and education)—with exclusive Italian distribution of GE HealthCare diagnostic imaging systems (ultrasound, radiology, mammography, densitometry). The company sells, installs, and supports this portfolio directly to hospitals, ASLs (local health authorities), research institutions, and educational facilities in Italy.
Is Predict a public or private company?
Predict is a public company. It is classified as public and is currently operating.
When was Predict founded?
Predict was founded in 2008. It employs 11 to 50 people.
Where is Predict based?
Predict is headquartered in Bari, Italy, in the Europe region.
How does Predict make money?
Four revenue lines are on record. Diagnostic Imaging Equipment Sales are the primary driver. The others are digital Healthcare Platforms, professional Services and digital Healthcare Solutions.
Who are Predict's main competitors?
Direct peers on record are Esaote and Owlstone Medical. Broad incumbents are Philips Healthcare, Intuitive Surgical, Hologic, Siemens Healthineers, GE HealthCare and Mindray. Emerging players are Tempus AI and Teladoc Health.
Does Predict have an API?
No public API is recorded for Predict.
What industry is Predict in?
Predict's product category is Healthcare Technology (Medical Imaging & Digital Health). Its primary akta.pro industry code is HDAAAEAH, Medical Imaging AI, with a secondary code of HLACALAD, Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic). Its NAICS code is 621512 and its SIC code is 3841.